Geode Capital Management LLC Acquires 4,477 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Geode Capital Management LLC lifted its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 1.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 343,073 shares of the company’s stock after acquiring an additional 4,477 shares during the quarter. Geode Capital Management LLC owned approximately 2.27% of U.S. Physical Therapy worth $29,040,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in USPH. Precision Wealth Strategies LLC lifted its holdings in U.S. Physical Therapy by 5.1% during the 3rd quarter. Precision Wealth Strategies LLC now owns 2,824 shares of the company’s stock valued at $239,000 after purchasing an additional 137 shares during the last quarter. Louisiana State Employees Retirement System lifted its stake in shares of U.S. Physical Therapy by 2.7% during the 2nd quarter. Louisiana State Employees Retirement System now owns 7,600 shares of the company’s stock worth $702,000 after buying an additional 200 shares during the last quarter. Martin Capital Advisors LLP boosted its holdings in shares of U.S. Physical Therapy by 1.6% during the 3rd quarter. Martin Capital Advisors LLP now owns 13,138 shares of the company’s stock worth $1,112,000 after buying an additional 201 shares during the period. First Horizon Advisors Inc. grew its stake in U.S. Physical Therapy by 25.1% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company’s stock valued at $126,000 after buying an additional 298 shares during the last quarter. Finally, Canada Pension Plan Investment Board bought a new position in U.S. Physical Therapy in the 2nd quarter valued at about $28,000.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on USPH shares. JPMorgan Chase & Co. boosted their price objective on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a report on Tuesday, December 3rd. JMP Securities initiated coverage on U.S. Physical Therapy in a research report on Monday, December 16th. They set an “outperform” rating and a $113.00 price objective on the stock. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Monday, December 16th. Barrington Research restated an “outperform” rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Finally, Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and upped their price target for the stock from $100.00 to $115.00 in a report on Monday, December 16th. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $114.00.

U.S. Physical Therapy Stock Performance

U.S. Physical Therapy stock opened at $91.87 on Friday. The stock has a market cap of $1.39 billion, a PE ratio of 97.73, a P/E/G ratio of 4.23 and a beta of 1.46. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy, Inc. has a 12-month low of $76.18 and a 12-month high of $113.63. The business’s 50-day moving average price is $91.39 and its two-hundred day moving average price is $89.58.

U.S. Physical Therapy Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 6th. Investors of record on Friday, November 15th were given a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a yield of 1.92%. The ex-dividend date was Friday, November 15th. U.S. Physical Therapy’s dividend payout ratio is 187.23%.

Insider Activity

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the company’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $96.25, for a total value of $49,665.00. Following the completion of the transaction, the chief financial officer now directly owns 20,469 shares in the company, valued at approximately $1,970,141.25. This represents a 2.46 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction on Friday, November 8th. The stock was sold at an average price of $96.29, for a total transaction of $166,003.96. Following the transaction, the chief operating officer now owns 7,106 shares in the company, valued at approximately $684,236.74. This trade represents a 19.52 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 7,412 shares of company stock worth $706,605. Insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.